Insulin sensitivity improvement of fermented Korean red ginseng (Panax ginseng) mediated by insulin resistance hallmarks in old-aged ob/ob mice

Journal of Ginseng Research

Volumn 39, Issue 4, 2015, Pages 331-337

  Cheon, Jeong Mu ^a   Kim, Dae Ik ^b   Kim, Kil Soo ^a  

^a Kyungpook National University   (South Korea)

^b Daegu Technopark Oriental Medicine Industry Support Center   (South Korea)

Author keywords

Fermented red ginseng; Hypoglycemic effect; Insulin sensitivity; Ob ob mice; Panax ginseng

Indexed keywords

CHOLESTEROL; FATTY ACID; GINSENG EXTRACT; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; LIPOPROTEIN LIPASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); TRIACYLGLYCEROL;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; FERMENTED PRODUCT; GENE EXPRESSION; GINSENG; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER HISTOLOGY; MOUSE; NONHUMAN; OB/OB MOUSE; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 84942836816     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgr.2015.03.005     Document Type: Article

References (46)

1. World Health Organization. Obesity. Available from: http://www.who.int/ topics/obesity/en/. [2015.03.08]
2. May AL, Freedman D, Sherry B, Blanck HM. ObesitydUnited States, 1999e 2010. MMWR Surveill Summ 2013;62:120-8.
3. Kopelman PG. Obesity as a medical problem. Nature 2000;404:635-43.
4. World Health Organization. Diabetes. Available from: http://www.who.int/ topics/diabetes_mellitus/en/. [2015.03.08]
5. Rose DP, Haffner SM, Baillargeon J. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 2007;28:763-77.
6. Singla P, Bardoloi A, Parkash AA. Metabolic effects of obesity: a review. World J Diabetes 2010;1:76-88.
7. Lee L. Introducing herbal medicine into conventional health care settings. J Nurse Midwifery 1999;44:253-66.
8. Cicero AFG, Derosa G, Gaddi A. What do herbalists suggest to diabetic patients in order to improve glycemic control? Evaluation of scientific evidence and potential risks. Acta Diabetol 2004;41:91-8.
9. Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Arch Med Sci 2008;4:285-92.
10. Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol 2009;15:3073-85.
11. Kim ST, Jang JH, Kwon JH, Moon KD. Change in the chemical components of red and white ginseng after puffing. Korean J Food Preserv 2009;16:355-61.
12. Xie JT, Zhou YP, Dey L, Attele AS, Wu JA, Gu M, Polonsky KS, Yuan CS. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 2002;9:254-8.
13. Zhao SJ, Li CY, Qian YC, Luo XP, Zhang X, Wang XS, Kang BY. Induction of hairy roots of Panax ginseng and studies on suitable culture condition of ginseng hairy roots. Chin J Biotechnol 2004;20:215-20.
14. Xie JT, Wang CZ, Ni M, Wu JA, Mehendale SR, Aung HH, Foo A, Yuan CS. American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice. J Food Sci 2007;72:S590-4.
15. Jung JW, Kang HR, Ji GE, Park MS, Song WJ, Kim MH, Kwon JW, Kim TW, Park HW, Cho SH, et al. Therapeutic effects of fermented red ginseng in allergic rhinitis: a randomized, double-blind, placebo-controlled study. Allergy Asthma Immunol Res 2011;3:103-10.
16. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:540-3.
17. Kim HJ, Chae IG, Lee SG, Jeong HJ, Lee EJ, Lee IS. Effects of fermented red ginseng extracts on hyperglycemia in streptozotocin-induced diabetic rats. J Ginseng Res 2010;34:104-12.
18. Biggs ML, Mukamal KJ, Luchsinger JA, Ix JH, Carnethon MR, Newman AB, de Boer IH, Strotmeyer ES, Mozaffarian D, Siscovick DS. Association between adiposity in midlife and older age and risk of diabetes in older adults. J Am Med Assoc 2010;303:2504-12.
19. Yuan CS, Attele AS, Zhang L, Lynch JP, Xie JT, Shi JQ. Leptin reduces body weight gain in neonatal rats. Pediatr Res 2000;48:380-3.
20. Kim SH, Hyun SH, Choung SY. Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. J Ethnopharmacol 2006;104:119-23.
21. Muoio DM, Lynis DG. Peripheral metabolic actions of leptin. Best Pract Res Clin Endocrinol Metab 2002;16:653-66.
22. Lindstrom P. The physiology of obese-hyperglycemic mice [ob/ob mice]. ScientificWorldJournal 2007;7:666-85.
23. Brüning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 1997;88:561-72.
24. Eckel RH. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 1989;320:1060-8.
25. Zechner R. The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism. Curr Opin Lipidol 1997;8:77-88.
26. Pulawa LK, Eckel RH. Overexpression of muscle lipoprotein lipase and insulin sensitivity. Curr Opin Clin Nutr Metab Care 2002;5:569-74.
27. Wang H, Knaub LA, Jensen DR, Jung DY, Hong EG, Ko HJ, Coates AM, Goldberg IJ, Becky A, Janssen RC, et al. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues. Diabetes 2009;58:116-24.
28. Cruz WS, Kwon G, Marshall CA, McDaniel ML, Semenkovich CF. Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells. J Biol Chem 2001;276:12162-8.
29. Lopez V, Saraff K, Medh JD. Down-regulation of lipoprotein lipase increases glucose uptake in L6 muscle cells. Biochem Biophys Res Commun 2009;389: 34-9.
30. Craik JD, Young JD, Cheeseman CI. GLUT-1 mediation of rapid glucose transport in dolphin (tursiops truncatus) red blood cells. Am J Physiol Regul Integr Comp Physiol 1998;274:R112-9.
31. Shepherd PR, Kahn BB. Glucose transporters and insulin actiondimplications for insulin resistance and diabetes mellitus. N Engl J Med 1999;341:248-57.
32. Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, Lowell BB, Wojtaszewski JFP, Hirshman MF, Virkamaki A, Goodyear LJ, et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 2000;6:924-8.
33. Hruz PW, Mueckler MM. Structural analysis of the GLUT1 facilitative glucose transporter. Mol Membr Biol 2001;18:183-93.
34. Levine KB, Cloherty EK, Hamill S, Carruthers A. Molecular determinants of sugar transport regulation by ATP. Biochemistry 2002;41:12629-38.
35. Thorens B, Mueckler M. Glucose transporters in the 21st century. Am J Physiol Endocrinol Metab 2010;298:E141-5.
36. Barroso I, Gurnell M, Crowley VEF, Agostini M, Schwabe JW, Soos MA, Maslen GLI, Williams TDM, Lewis H, Schafer AJ, et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999;402:880-3.
37. Herzig S, Hedrick S, Morantte I, Koo SH, Galimi F, Montminy M. CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma. Nature 2003;426:190-3.
38. Rangwala SM, Lazar MA. Peroxisome proliferator-activated receptor g in diabetes and metabolism. Trends Pharmacol Sci 2004;25:331-6.
39. Rangwala SM, Rhoades B, Shapiro JS, Rich AS, Kim JK, Shulman GI, Kaestner KH, Lazar MA. Genetic modulation of PPAR g phosphorylation regulates insulin sensitivity. Dev Cell 2003;5:657-63.
40. Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, Wilkes J, Evans RM, Olefsky J. Muscle-specific Pparg deletion causes insulin resistance. Nat Med 2003;9:1491-7.
41. Newsholme EA, Williams T. The role of phosphoenolpyruvate carboxykinase in amino acid metabolism in muscle. Biochem J 1978;176:623-6.
42. Nye CK, Hanson RW, Kalhan SC. Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat. J Biol Chem 2008;283: 27565-74.
43. Yang J, Kalhan SC, Hanson RW. What is the metabolic role of phosphoenolpyruvate carboxykinase? J Biol Chem 2009;284:27025-9.
44. She P, Burgess SC, Shiota M, Flakoll P, Donahue EP, Malloy CR, Sherry AD, Magnuson MA. Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation. Diabetes 2003;52:1649-54.
45. Cha JY, Park JC, Ahn HY, Eom KE, Park BK, Jun BS, Lee CH, Cho YS. Effect of Monascus purpureus-Korean Red Ginseng power on the serum lipid levels and antioxidative activity in rats. J Korean Soc Food Sci Nutr 2009;38:1153-60.
46. Mollah ML, Kim GS, Moon HK, Chung SK, Cheon YP, Kim JK, Kim KS. Antiobesity effects of wild ginseng (Panax ginseng CA Meyer) mediated by PPAR-g, GLUT4 and LPL in ob/ob mice. Phytother Res 2009;23:220-5.